Добірка наукової літератури з теми "Immune-related adverse effects (irAEs)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Immune-related adverse effects (irAEs)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Immune-related adverse effects (irAEs)"
Naing, Aung, Joud Hajjar, James L. Gulley, Michael B. Atkins, Gennaro Ciliberto, Funda Meric-Bernstam, and Patrick Hwu. "Strategies for improving the management of immune-related adverse events." Journal for ImmunoTherapy of Cancer 8, no. 2 (December 2020): e001754. http://dx.doi.org/10.1136/jitc-2020-001754.
Повний текст джерелаReynolds, Kerry Lynn, Justine Vanessa Cohen, Sienna Durbin, Molly Thomas, Michael Dougan, Holly S. Martinson, Alex Faje, et al. "Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: A tsunami is coming, but are we ready?" Journal of Clinical Oncology 36, no. 5_suppl (February 10, 2018): 127. http://dx.doi.org/10.1200/jco.2018.36.5_suppl.127.
Повний текст джерелаChen, Ru, Min Zhou, and Feng Zhu. "Immune Checkpoint Inhibitors Related to Cardiotoxicity." Journal of Cardiovascular Development and Disease 9, no. 11 (November 3, 2022): 378. http://dx.doi.org/10.3390/jcdd9110378.
Повний текст джерелаKawahira, Machiko, Shuji Kanmura, Keiko Mizuno, Kentaro Machida, Takao Ohtsuka, Masami Sato, Hideki Enokida, et al. "Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events." PLOS ONE 17, no. 4 (April 28, 2022): e0267572. http://dx.doi.org/10.1371/journal.pone.0267572.
Повний текст джерелаWang, QuanQiu, and Rong Xu. "Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis." JAMIA Open 2, no. 1 (October 15, 2018): 173–78. http://dx.doi.org/10.1093/jamiaopen/ooy045.
Повний текст джерелаCoschi, Courtney H., and Rosalyn A. Juergens. "The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer." Current Oncology 28, no. 6 (November 2, 2021): 4392–407. http://dx.doi.org/10.3390/curroncol28060373.
Повний текст джерелаThapa, Bicky, Joanna Roopkumar, Ann S. Kim, Lorenzo Gervaso, Pradnya Dinkar Patil, Cassandra Calabrese, Alok A. Khorana, and Pauline Funchain. "Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI)." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e14151-e14151. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14151.
Повний текст джерелаKapoor, Akhil, Vanita Noronha, Vijay Maruti Patil, Amit Joshi, Nandini Sharrel Menon, and Kumar Prabhash. "Association of immune-related adverse effects and survival in responders treated with immune checkpoint inhibitors." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e15172-e15172. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e15172.
Повний текст джерелаRodriguez, Benigno, José Fabián Martínez-Herrera, Lorena López Zepeda, Guillermo Olivares, Alberto Villalobos, Fernando Perez, Christian Patricio Camacho Limas, et al. "Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e21522-e21522. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e21522.
Повний текст джерелаKim, Sarah, A. Dimitrios Colevas, Stephanie Tse, Sandy On, and Edna Cheung. "Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 2661. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2661.
Повний текст джерелаКниги з теми "Immune-related adverse effects (irAEs)"
Drug-induced immune diseases. Amsterdam: Elsevier, 1990.
Знайти повний текст джерелаImmunotoxicity testing: Methods and protocols. New York, NY: Humana Press, 2010.
Знайти повний текст джерелаDietert, Rodney R. Immunotoxicity Testing: Methods and Protocols. Humana Press, 2016.
Знайти повний текст джерелаCoyle, Patricia K. Immune-mediated Disorders of the Central Nervous System. Edited by Emma Ciafaloni, Cheryl Bushnell, and Loralei L. Thornburg. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190667351.003.0010.
Повний текст джерелаЧастини книг з теми "Immune-related adverse effects (irAEs)"
Meara, Alexa Simon, and Leonard H. Calabrese. "Management of Rheumatic Immune-Related Adverse Events (irAEs): General Principles." In Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy, 309–21. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-56824-5_14.
Повний текст джерелаE. Omar, Nabil, Hebatalla M. Afifi, Arwa O. Sahal, Rana Mekkawi, and Hazem Elewa. "The Flip of the Coin of Personalized Cancer Immunotherapy: A Focused Review on Rare Immune Checkpoint Related Adverse Effects." In Immune Checkpoint Inhibitors - New Insights and Recent Progress [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.107833.
Повний текст джерелаRivera-Grana, Erick, and Stephanie M. Llop. "Immunotherapy-Associated Uveitis." In Eye Diseases - Recent Advances, New Perspectives and Therapeutic Options [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.106442.
Повний текст джерелаMoran, Carla. "Endocrine Complications of Biological Cancer Therapies." In Oxford Textbook of Endocrinology and Diabetes 3e, edited by John A. H. Wass, Wiebke Arlt, and Robert K. Semple, 1774–78. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198870197.003.0218.
Повний текст джерелаPatel, Anush, Haisam Abid, and Amrat Kumar. "The Endocrinological Side Effects of Immunotherapies." In Advances in Precision Medicine Oncology. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96491.
Повний текст джерелаMemis Bilgin, Yavuz. "Clinical Effects and Possible Mechanisms of Transfusion-Related Immunomodulation." In Blood Donation and Transfusion [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.107228.
Повний текст джерелаBhattacharyya, Joya, and Arthur Kaser. "Immune disorders of the gastrointestinal tract." In Oxford Textbook of Medicine, edited by Jack Satsangi, 2783–96. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0292.
Повний текст джерелаBurton, Rosie, and Ana Houston. "HIV medicine." In Oxford Handbook of Tropical Medicine 5e, 69–142. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198810858.003.0003.
Повний текст джерелаMolitch, Mark E., and Jelena Kravarusic. "Lymphocytic Hypophysitis and other Inflammatory Conditions of the Pituitary." In Oxford Textbook of Endocrinology and Diabetes 3e, edited by John A. H. Wass, Wiebke Arlt, and Robert K. Semple, 304–12. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198870197.003.0035.
Повний текст джерелаPerera, Frederica. "A Myriad of Health Impacts from Fossil Fuel." In Children's Health and the Peril of Climate Change, 46—C3.S27. Oxford University PressNew York, 2022. http://dx.doi.org/10.1093/oso/9780197588161.003.0003.
Повний текст джерелаТези доповідей конференцій з теми "Immune-related adverse effects (irAEs)"
Sklodowski, Kamil, Vito Dozio, Roberta Poli, Andrés Lanzós, Silvia Lopez-Lastra, Kristina Beeler, and Emanuela Romano. "Abstract 1615: Immune-related adverse effects (irAEs) associated proteomic profile in late-stage NSCLC patients after PD-1 blockade." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1615.
Повний текст джерелаKaakour, Dalia, Matthew Slaught, Armon Azizi, Gianna Kroening, Jennifer Valerin, and Nataliya Mar. "1247 Distribution of immune-related adverse events (irAEs) in solid malignancies." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.1247.
Повний текст джерелаEnnis, D., F. To, and S. Jamal. "THU0615 Immune related adverse events (IRAES) associated with checkpoint inhibitors: 12 cases from a single centre." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6009.
Повний текст джерелаLiu, Jing, Stephten J. Blake, Kirsten A. Fairfax, Michelle C. R. Yong, Stacey Allen, Mark J. Smyth, and Michele W. L. Teng. "Abstract B122: A preclinical mouse model to assess antitumor efficacy and development of immune related adverse events (irAEs) following combination immunotherapies." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b122.
Повний текст джерелаDavis, Andrew A., Jonghanne Park, Leeseul Kim, Gahyun Gim, Wade T. Iams, Michael S. Oh, Robert W. Lentz, et al. "Abstract 5527: Serum proteomic scores for understanding the mechanisms of immune-related adverse events (irAEs) in non-small cell lung cancer." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5527.
Повний текст джерелаRichter, M. D., C. S. Crowson, L. A. Kottschade, H. D. Finnes, S. N. Markovic, and U. Thanarajasingam. "SAT0588 Rheumatologic immune-related adverse effects of checkpoint inhibitor therapy: a single centrecohort of 29 patients." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.2645.
Повний текст джерелаKandolf Sekulović, Lidija. "TOXICITIES OF TARGETED THERAPY AND IMMUNE-RELATED ADVERSE DRUG REACTIONS OF IMMUNOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA." In Okrugli sto s međunarodnim učešćem "Melanom". Akademija nauka i umjetnosti Bosne i Hercegovine, 2018. http://dx.doi.org/10.5644/pi2019.180.04.
Повний текст джерелаKostine, M., E. Mauric, L. Rouxel, T. Barnetche, R. Veillon, F. Martin, C. Dutriaux, et al. "OP0088 Immune-related adverse events of cancer immunotherapy – when inflammatory side effects are associated with survival: a single-centre prospective cohort study." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3783.
Повний текст джерелаMONBRUN, Mathilde, Léo Grassion, Elodie Blanchard, Rémi Veillon, Maeva Zysman, and Chantal Raherison. "Influenza and Pneumococcal vaccination effects on the immune-related adverse events in patients under immunotherapy for an advanced stage non-small cell lung cancer." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2303.
Повний текст джерела